EMEA gives positive opinions to five new medicines

Monday 29 June 2009

Five new medicines, including a cell-based treatment for cartilage defects, have received positive opinions from the European Medicines Agency, paving the way for the issuing of marketing authorisations by the European Commission.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United Kingdom

See map: Google Maps